Company Information for 4D PHARMA RESEARCH LIMITED
C/O INTERPATH LIMITED 5TH FLOOR, 130 ST. VINCENT STREET, GLASGOW, G2 5HF,
|
Company Registration Number
SC336222
Private Limited Company
In Administration |
Company Name | ||||
---|---|---|---|---|
4D PHARMA RESEARCH LIMITED | ||||
Legal Registered Office | ||||
C/O INTERPATH LIMITED 5TH FLOOR 130 ST. VINCENT STREET GLASGOW G2 5HF Other companies in AB25 | ||||
Previous Names | ||||
|
Company Number | SC336222 | |
---|---|---|
Company ID Number | SC336222 | |
Date formed | 2008-01-15 | |
Country | ||
Origin Country | United Kingdom | |
Type | Private Limited Company | |
CompanyStatus | In Administration | |
Lastest accounts | 31/12/2021 | |
Account next due | 30/09/2023 | |
Latest return | 15/01/2016 | |
Return next due | 12/02/2017 | |
Type of accounts | FULL | |
VAT Number /Sales tax ID |
Last Datalog update: | 2023-06-05 18:54:16 |
Companies House |
Menu
|
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |
Officer | Role | Date Appointed |
---|---|---|
LAURENCE SMITH DALE |
||
DUNCAN JOSEPH PEYTON |
||
ALEXANDER JAMES STEVENSON |
Officer | Role | Date Appointed | Date Resigned |
---|---|---|---|
DOUGLAS CAMPBELL THOMSON |
Director | ||
THOMAS ENGELEN |
Director | ||
DENISE KELLY |
Director | ||
KEITH DAVID ROY WINTON |
Company Secretary | ||
HOWARD JOHN MARRIGE |
Director | ||
MACLAY MURRAY & SPENS LLP |
Nominated Secretary | ||
VINDEX LIMITED |
Nominated Director | ||
VINDEX SERVICES LIMITED |
Nominated Director |
Officer | Related Company | Role | Date Appointed | Role Status | Incorporation date | Company Status |
---|---|---|---|---|---|---|
THE MICROBIOTA COMPANY LIMITED | Director | 2014-07-17 | CURRENT | 2014-07-15 | Active - Proposal to Strike off | |
MICROBIOMICS LIMITED | Director | 2014-04-01 | CURRENT | 2014-01-31 | Active - Proposal to Strike off | |
4D PHARMA PLC | Director | 2014-01-18 | CURRENT | 2014-01-10 | In Administration | |
SCHOSWEEN 18 LIMITED | Director | 2013-11-28 | CURRENT | 2013-11-28 | Dissolved 2017-09-19 | |
AQUARIUS PHARMA LIMITED | Director | 2013-06-24 | CURRENT | 2013-06-24 | Active - Proposal to Strike off | |
AQUARIUS LIFE SCIENCE LIMITED | Director | 2012-11-07 | CURRENT | 2012-11-07 | Active - Proposal to Strike off | |
AQUARIUS IV FUND MANAGING MEMBER LIMITED | Director | 2010-10-05 | CURRENT | 2010-02-24 | Active - Proposal to Strike off | |
AQUARIUS ORIGIN FUND MANAGING MEMBER LIMITED | Director | 2009-04-03 | CURRENT | 2009-03-02 | Active - Proposal to Strike off | |
NORTH WEST SEED FUND GENERAL PARTNER LIMITED | Director | 2009-01-28 | CURRENT | 2003-08-18 | Active - Proposal to Strike off | |
NORTH WEST SEED FUND FOUNDER PARTNER LIMITED | Director | 2009-01-28 | CURRENT | 2003-08-18 | Active - Proposal to Strike off | |
AQUARIUS NORTHERN ENTREPRENEURS MANAGING MEMBER LIMITED | Director | 2006-07-25 | CURRENT | 2006-07-25 | Active - Proposal to Strike off | |
AQUARIUS EQUITY HOLDINGS LIMITED | Director | 2005-07-12 | CURRENT | 2005-02-07 | Active - Proposal to Strike off | |
AQUARIUS EQUITY DIRECTOR LIMITED | Director | 2004-09-01 | CURRENT | 2004-07-02 | Active - Proposal to Strike off | |
AQUARIUS EQUITY PARTNERS LIMITED | Director | 2004-08-19 | CURRENT | 2002-06-26 | Active - Proposal to Strike off | |
C4X DISCOVERY HOLDINGS PLC | Director | 2014-09-03 | CURRENT | 2014-07-16 | Active | |
AQUARIUS EQUITY DIRECTOR LIMITED | Director | 2014-08-20 | CURRENT | 2004-07-02 | Active - Proposal to Strike off | |
AQUARIUS IV FUND MANAGING MEMBER LIMITED | Director | 2014-08-20 | CURRENT | 2010-02-24 | Active - Proposal to Strike off | |
AQUARIUS ORIGIN FUND MANAGING MEMBER LIMITED | Director | 2014-08-20 | CURRENT | 2009-03-02 | Active - Proposal to Strike off | |
THE MICROBIOTA COMPANY LIMITED | Director | 2014-07-17 | CURRENT | 2014-07-15 | Active - Proposal to Strike off | |
AQUARIUS LIFE SCIENCE LIMITED | Director | 2014-05-28 | CURRENT | 2012-11-07 | Active - Proposal to Strike off | |
MICROBIOMICS LIMITED | Director | 2014-04-01 | CURRENT | 2014-01-31 | Active - Proposal to Strike off | |
4D PHARMA PLC | Director | 2014-01-18 | CURRENT | 2014-01-10 | In Administration | |
NORTH WEST SEED FUND GENERAL PARTNER LIMITED | Director | 2013-12-19 | CURRENT | 2003-08-18 | Active - Proposal to Strike off | |
SCHOSWEEN 18 LIMITED | Director | 2013-11-28 | CURRENT | 2013-11-28 | Dissolved 2017-09-19 | |
AQUARIUS NORTHERN ENTREPRENEURS MANAGING MEMBER LIMITED | Director | 2013-07-23 | CURRENT | 2006-07-25 | Active - Proposal to Strike off | |
AQUARIUS EQUITY PARTNERS LIMITED | Director | 2008-05-02 | CURRENT | 2002-06-26 | Active - Proposal to Strike off | |
AQUARIUS EQUITY HOLDINGS LIMITED | Director | 2008-05-02 | CURRENT | 2005-02-07 | Active - Proposal to Strike off |
Job Title | Location | Job description | Date posted |
---|---|---|---|
Preclinical Research Assistant / Scientist | Aberdeen City | *Job Description- Preclinical Models Research Assistant / Scientist* *About the Company* 4D Pharma PLC is a pharmaceutical company focussed on developing | |
Senior Microbiologist | Aberdeen City | Applications are invited for the role of Senior Microbiologist to join the research team at 4D Pharma Research Ltd in Aberdeen (UK).... | |
Division Head (II) | Aberdeen City | 4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome. Job Description- Division Head (Discovery II)*.... | |
Division Head (I) | Aberdeen City | 4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome. Job Description- Division Head (Discovery I)*.... | |
Research Technician in Molecular Microbiology | Aberdeen City | 4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome. About the Company*.... | |
Clinical Trial Administrator (CTA) | Aberdeen City | 4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome. Clinical Trial Administrator (CTA)*.... | |
Senior Administrator/HR Manager | Aberdeen City | Applications are invited for an exciting new Senior Administrator/HR Manager position at 4D Pharma plc. 4D Pharma is a pharmaceutical company focussed on | |
Immunologist | Aberdeen City | 4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome.... | |
Cell Biologist/Physiologist | Aberdeen City | Applications are invited for an exciting new research position at 4D Pharma Research Ltd in Aberdeen (UK). 4D Pharma PLC is a pharmaceutical company focussed on... | |
Molecular Microbiologist | Aberdeen City | 4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome.... | |
Microbiologist Isolation | Aberdeen City | 4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome.... | |
Industrial Microbiologist | Aberdeen City | 4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome.... | |
Laboratory Technician | Aberdeen City | Applications are invited for a new position of Laboratory Technician in the Research group of 4D Pharma (Aberdeen). The post holder will be an integral part of | |
Clinical Microbiologist | Aberdeen City | 4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome.... | |
Laboratory Technician | Aberdeen City | Applications are invited for a new position of Laboratory Technician in the Research group of 4D Pharma (Aberdeen). The post holder will be an integral part of | |
Microbiology Fermentation Technician | Aberdeen City | This will involve the daily operation of fermentation equipment, media preparation, and laboratory maintenance.... | |
Molecular Microbiologist | Aberdeen City | 4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome.... | |
Immunologist | Aberdeen City | 4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome.... | |
Cell Biologist/Physiologist | Aberdeen City | 4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome.... | |
Microbiologist Isolation | Aberdeen City | 4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome.... | |
Industrial Microbiologist | Aberdeen City | 4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome.... | |
Clinical Microbiologist | Aberdeen City | 4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome.... | |
Microbiology Research Assistant/Scientist | Aberdeen City | The candidate will lead the development of innovative microbial characterisation technologies to drive forward the proprietary MicroRx discovery platform.... |
Date | Document Type | Document Description |
---|---|---|
Error | ||
Error | ||
Error | ||
Error | ||
REGISTERED OFFICE CHANGED ON 05/04/23 FROM Life Science Innovation Building Cornhill Road Aberdeen AB25 2ZS | ||
APPOINTMENT TERMINATED, DIRECTOR ALEXANDER JAMES STEVENSON | ||
APPOINTMENT TERMINATED, DIRECTOR ALEXANDER JAMES STEVENSON | ||
Termination of appointment of Duncan Peyton on 2023-03-16 | ||
APPOINTMENT TERMINATED, DIRECTOR DUNCAN JOSEPH PEYTON | ||
APPOINTMENT TERMINATED, DIRECTOR DUNCAN JOSEPH PEYTON | ||
Error | ||
Error | ||
CONFIRMATION STATEMENT MADE ON 07/01/23, WITH NO UPDATES | ||
MR01 | REGISTRATION OF A CHARGE / CHARGE CODE SC3362220005 | |
AA | FULL ACCOUNTS MADE UP TO 31/12/21 | |
CONFIRMATION STATEMENT MADE ON 07/01/22, WITH NO UPDATES | ||
CS01 | CONFIRMATION STATEMENT MADE ON 07/01/22, WITH NO UPDATES | |
MR01 | REGISTRATION OF A CHARGE / CHARGE CODE SC3362220003 | |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
RES13 | Resolutions passed:
| |
MR01 | REGISTRATION OF A CHARGE / CHARGE CODE SC3362220002 | |
AA | FULL ACCOUNTS MADE UP TO 31/12/20 | |
CS01 | CONFIRMATION STATEMENT MADE ON 07/01/21, WITH NO UPDATES | |
AA | FULL ACCOUNTS MADE UP TO 31/12/19 | |
CS01 | CONFIRMATION STATEMENT MADE ON 07/01/20, WITH NO UPDATES | |
TM02 | Termination of appointment of Laurence Smith Dale on 2020-01-31 | |
AP03 | Appointment of Mr Duncan Peyton as company secretary on 2020-01-31 | |
AA | FULL ACCOUNTS MADE UP TO 31/12/18 | |
CS01 | CONFIRMATION STATEMENT MADE ON 07/01/19, WITH NO UPDATES | |
AA | FULL ACCOUNTS MADE UP TO 31/12/17 | |
LATEST SOC | 21/03/18 STATEMENT OF CAPITAL;GBP 1087.64 | |
CS01 | CONFIRMATION STATEMENT MADE ON 21/03/18, WITH UPDATES | |
SH10 | Particulars of variation of rights attached to shares | |
SH08 | Change of share class name or designation | |
RES12 | Resolution of varying share rights or name | |
RES01 | ADOPT ARTICLES 31/12/2017 | |
CS01 | CONFIRMATION STATEMENT MADE ON 30/12/17, WITH NO UPDATES | |
PSC05 | Change of details for 4D Pharma Plc as a person with significant control on 2017-09-01 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / MR ALEXANDER JAMES STEVENSON / 01/09/2017 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / MR DUNCAN JOSEPH PEYTON / 01/09/2017 | |
CH03 | SECRETARY'S DETAILS CHNAGED FOR LAURENCE SMITH DALE on 2017-09-01 | |
AA | FULL ACCOUNTS MADE UP TO 31/12/16 | |
LATEST SOC | 06/01/17 STATEMENT OF CAPITAL;GBP 1087.64 | |
CS01 | CONFIRMATION STATEMENT MADE ON 06/01/17, WITH UPDATES | |
AA | FULL ACCOUNTS MADE UP TO 31/12/15 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / MR ALEXANDER JAMES STEVENSON / 21/01/2016 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / MR DUNCAN JOSEPH PEYTON / 21/01/2016 | |
CH03 | SECRETARY'S DETAILS CHNAGED FOR LAURENCE SMITH DALE on 2016-01-21 | |
LATEST SOC | 22/01/16 STATEMENT OF CAPITAL;GBP 1087.64 | |
AR01 | 15/01/16 ANNUAL RETURN FULL LIST | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR DOUGLAS CAMPBELL THOMSON | |
AA | FULL ACCOUNTS MADE UP TO 31/12/14 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR THOMAS ENGELEN | |
CH01 | Director's details changed for Mr Duncan Joseph Peyton on 2015-03-25 | |
MISC | Sect 519 auditor's letter | |
RES15 | CHANGE OF NAME 30/03/2015 | |
CERTNM | Company name changed gt biologics LIMITED\certificate issued on 30/03/15 | |
LATEST SOC | 10/02/15 STATEMENT OF CAPITAL;GBP 1087.64 | |
AR01 | 15/01/15 FULL LIST | |
SH01 | 12/11/12 STATEMENT OF CAPITAL GBP 1087.64 | |
AA | 31/12/13 TOTAL EXEMPTION SMALL | |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
RES01 | ALTER ARTICLES 03/06/2014 | |
SH08 | NOTICE OF NAME OR OTHER DESIGNATION OF CLASS OF SHARES | |
SH10 | NOTICE OF PARTICULARS OF VARIATION OF RIGHTS ATTACHED TO SHARES | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
LATEST SOC | 31/01/14 STATEMENT OF CAPITAL;GBP 1023.92 | |
AR01 | 15/01/14 FULL LIST | |
SH01 | 04/12/13 STATEMENT OF CAPITAL GBP 1023.92 | |
AA | 31/12/12 TOTAL EXEMPTION SMALL | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR DENISE KELLY | |
AP01 | DIRECTOR APPOINTED MR DOUGLAS CAMPBELL THOMSON | |
AP01 | DIRECTOR APPOINTED ALEX STEVENSON | |
AD01 | REGISTERED OFFICE CHANGED ON 24/07/2013 FROM ROOM W05 LIFE SCIENCE INNOVATION BUILDING CORNHILL ROAD ABERDEEN AB25 2ZS SCOTLAND | |
SH01 | 28/06/13 STATEMENT OF CAPITAL GBP 523.92 | |
AD01 | REGISTERED OFFICE CHANGED ON 28/06/2013 FROM C/O C/O PROFESSOR DENISE KELLY ROOM 3.17 INSTITUTE OF MEDICAL SCIENCES FORESTERHILL ABERDEEN AB25 2ZD UNITED KINGDOM | |
AR01 | 15/01/13 FULL LIST | |
AP01 | DIRECTOR APPOINTED THOMAS ENGELEN | |
AP03 | SECRETARY APPOINTED LAURENCE SMITH DALE | |
AP01 | DIRECTOR APPOINTED MR DUNCAN JOSEPH PEYTON | |
TM02 | APPOINTMENT TERMINATED, SECRETARY KEITH WINTON | |
AD01 | REGISTERED OFFICE CHANGED ON 28/11/2012 FROM C/O THOERIS CONSULTANTS LTD 6 GREENBANK ROW EDINBURGH EH10 5SY SCOTLAND | |
SH01 | 12/11/12 STATEMENT OF CAPITAL GBP 440.59 | |
CC04 | STATEMENT OF COMPANY'S OBJECTS | |
RES11 | DISAPPLICATION OF PRE-EMPTION RIGHTS | |
RES13 | REMOVAL OF CURRENT AUTH SHARE CAPITAL, CREATION OF NEW A ORD SHARES 08/11/2012 | |
SH08 | NOTICE OF NAME OR OTHER DESIGNATION OF CLASS OF SHARES | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR HOWARD MARRIGE | |
AA | 31/12/11 TOTAL EXEMPTION SMALL | |
AR01 | 15/01/12 FULL LIST | |
AA | 31/12/10 TOTAL EXEMPTION SMALL | |
AR01 | 15/01/11 FULL LIST | |
AD01 | REGISTERED OFFICE CHANGED ON 05/01/2011 FROM WALLACE BUILDING ROSLIN BIOCENTRE ROSLIN EH25 9PP | |
SH01 | 31/10/10 STATEMENT OF CAPITAL GBP 290.59 | |
AA | 31/12/09 TOTAL EXEMPTION SMALL | |
AR01 | 15/01/10 FULL LIST | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / DR HOWARD JOHN MARRIGE / 15/01/2010 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / DENISE KELLY / 15/01/2010 | |
SH01 | 27/11/09 STATEMENT OF CAPITAL GBP 133.78 | |
AA | 31/12/08 TOTAL EXEMPTION SMALL | |
363a | RETURN MADE UP TO 15/01/09; FULL LIST OF MEMBERS | |
288a | DIRECTOR APPOINTED DR HOWARD JOHN MIRRAGE | |
225 | ACC. REF. DATE SHORTENED FROM 31/01/2009 TO 31/12/2008 | |
287 | REGISTERED OFFICE CHANGED ON 01/04/2008 FROM QUARTERMILE ONE 15 LAURISTON PLACE EDINBURGH EH3 9EP | |
123 | NC INC ALREADY ADJUSTED 12/03/08 | |
288b | APPOINTMENT TERMINATED SECRETARY MACLAY MURRAY & SPENS LLP | |
288a | DIRECTOR APPOINTED DENISE KELLY | |
288b | APPOINTMENT TERMINATED DIRECTOR VINDEX SERVICES LIMITED | |
288b | APPOINTMENT TERMINATED DIRECTOR VINDEX LIMITED | |
88(2) | AD 12/03/08 GBP SI 10400@0.01=104 GBP IC 2/106 | |
288a | SECRETARY APPOINTED DR KEITH DAVID ROY WINTON | |
122 | S-DIV | |
RES11 | DISAPPLICATION OF PRE-EMPTION RIGHTS | |
RES01 | ADOPT ARTICLES 12/03/2008 | |
CERTNM | COMPANY NAME CHANGED MM&S (5335) LIMITED CERTIFICATE ISSUED ON 14/03/08 | |
NEWINC | INCORPORATION DOCUMENTS CERTIFICATE OF INCORPORATION STATEMENT OF DIRECTORS & REGISTERED OFFICE DECLARATION OF COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION |
Appointmen | 2023-03-21 |
Total # Mortgages/Charges | 5 |
---|---|
Mortgages/Charges outstanding | 5 |
Mortgages Partially Satisifed | 0 |
Mortgages Satisfied/Paid | 0 |
|
|
|
These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on 4D PHARMA RESEARCH LIMITED
4D PHARMA RESEARCH LIMITED owns 4 domain names.
gt-therapeutics.co.uk gtprohealth.co.uk gttherapeutics.co.uk gt-prohealth.co.uk
The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as 4D PHARMA RESEARCH LIMITED are:
Initiating party | Event Type | Appointmen | |
---|---|---|---|
Defending party | 4D PHARMA RESEARCH LIMITED | Event Date | 2023-03-21 |
In the Court of Session No P234 of 23. 4D PHARMA RESEARCH LIMITED Company Number: SC336222 Previous Name of Company: GT BIOLOGICS LIMITED, MM&S (5335) LIMITED Nature of Business: Research and experime… | |||
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |